The beta-blocker propranolol (multiple brands) may improve social and cognitive impairment for patients with autism spectrum disorder (ASD), new research suggests.

Investigators found that for patients with autism, propranolol improved performance on a word generation test compared to placebo, and brain imaging results revealed that the drug altered regions of the brain associated with word processing and improved specific task information processing.

View Full Article

You need to login or register to bookmark/favorite this content.